A randomized, double-blind, placebo-controlled phase i trial of inhalation treatment of recombinant tff2-ifn protein: a multifunctional candidate for the treatment of covid-19

HIGHLIGHTS

SUMMARY

    IFNs activate nitric oxide synthase and several other pathways (Samuel, 2001; Lamers et_al, 2019). Trefoil factor 2 (TFF2) is a secreted polypeptide, that is, resistant to acid, heat, and protease hydrolysis and can protect the gastrointestinal tract and respiratory tract from microbial injury by promoting the repair of injury and regulating the immune_response (Poulsen et_al, 1999) (Baus-Loncar et_al, 2005) (Farrell et_al, 2002). The authors have previously tested this concept in SARS-CoV-2 infected patients during the first wave of the COVID-19 outbreak in 2020, and the results showed that the combination . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?